在心房的癌症患者中,左心房尾关闭
David Zweiker1,2, Jutta Bergler-Klein3, Lukas Fiedler4
1Division of Cardiology, Medical University of Graz, 8036 Graz, Austria.
Journal of clinical medicine
|November 9, 2024
概括
左心房尾关闭 (LAAC) 是癌症患者的安全有效治疗方法,其结果与没有癌症患者的结果相似. 这项研究证实了LAAC的研究结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 在瘤学瘤学.
背景情况:
- 有限的数据存在于癌症患者的左心房尾关闭 (LAAC).
- 本研究涉及LAAC在该人群中的安全性和有效性.
研究的目的:
- 为了比较LAAC在有癌症史和没有癌症史的患者中的结果.
- 评估基线特征与这些群体的结果之间的关系.
主要方法:
- 关于未来奥地利LAAC注册的部分分析.
- 包括连续486名患者,其中57人有癌症病史.
- 使用逆概率加权来调整基线特征差异.
主要成果:
- 癌症患者年龄较大,贫血和胃肠道出血率较高.
- 在重大手术并发症 (5.3%与7.0%) 中没有显著差异.
- 在不同组之间,相似的5年生存率 (80.7%vs. 84.8%) 和1年生存率 (96.1%vs. 94.0%) 是相似的.
结论:
- 在临床实践中,LAAC是癌症患者接受的治疗选择.
- 在癌症和非癌症患者中,LAAC的短期和长期结果是可比的.
- 这支持在选定的癌症患者中使用LAAC.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


